<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02470962</url>
  </required_header>
  <id_info>
    <org_study_id>DMD-Herz</org_study_id>
    <nct_id>NCT02470962</nct_id>
  </id_info>
  <brief_title>Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy</brief_title>
  <official_title>Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Children's Hospital, Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Children's Hospital, Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the function of the heart in young patients with muscular dystrophy type
      Duchenne or Becker. Participants have their hearts examined at regular intervals by
      ultrasound (echocardiography) and cardiac magnetic resonance imaging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscular dystrophy leads to progressive loss of function in all muscles during childhood and
      adolescence, including the heart. The usual method to evaluate the heart is echocardiography,
      emphasizing few parameters. Cardiac magnetic resonance imaging is not as widely available as
      echocardiography, but early changes can be detected before they become visible on
      echocardiography. In this study, the investigators compare the methods of measuring heart
      function in order to find the best measurements for follow up and to see how fast the
      degenerative changes occur in the hearts of patients with muscular dystrophy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>3 years per patient</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of fibrosis by LGE/T1 mapping</measure>
    <time_frame>3 years per patient</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NT-proBNP</measure>
    <time_frame>3 years per patient</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Duchenne / Becker Muscular Dystrophy</condition>
  <arm_group>
    <arm_group_label>Patients with muscular dystrophy</arm_group_label>
    <description>Boys aged 8 to 18 years with muscular dystrophy of the Duchenne / Becker type</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children without heart disease</arm_group_label>
    <description>Children without heart disease, aged 8-18 years, as CMR comparison group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Observation by serial echocardiography with extended techniques and cardiac magnetic resonance imaging</description>
    <arm_group_label>Children without heart disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Boys aged 8 to 18 years with DMD/BMD confirmed genetically or by muscle biopsy

          -  Control group for CMR: children without heart disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Boys aged 8 to 18 years with DMD/BMD confirmed genetically or by muscle biopsy

          -  Informed consent

        Exclusion Criteria:

          -  Other clinically significant concomitant disease states (e.g., renal failure)

          -  Inability to follow the procedures of the study, e.g. due to language problems,
             psychological disorders, dementia, etc. of the participant or his/her parents or legal
             caregivers,

          -  Inability to lie still for the duration of the imaging procedures (approximately 45
             minutes each for echocardiography and CMR)

          -  MR-incompatible implanted or accidentally incorporated metal device or claustrophobia
             that prohibits use of magnetic resonance imaging
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara EU Burkhardt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Zürich, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hilfiker Silvia</last_name>
    <phone>+41442663339</phone>
    <email>silvia.hilfiker@kispi.uzh.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Hospital</name>
      <address>
        <city>Zürich</city>
        <state>ZH</state>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Hilfiker</last_name>
      <phone>+41442663339</phone>
      <email>silvia.hilfiker@kispi.uzh.ch</email>
    </contact>
    <contact_backup>
      <last_name>Barbara EU Burkhardt, MD</last_name>
      <phone>+41442667062</phone>
      <email>barbara.burkhardt@kispi.uzh.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Emanuela R Valsangiacomo Büchel, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Klein, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2015</study_first_submitted>
  <study_first_submitted_qc>June 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2015</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

